|
C12ORF49 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.772500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.016990E-04 |
| Normal-vs-Stage2 |
2.134200E-01 |
| Normal-vs-Stage3 |
3.529900E-02 |
| Normal-vs-Stage4 |
1.369000E-01 |
| Stage1-vs-Stage2 |
1.372820E-01 |
| Stage1-vs-Stage3 |
9.687800E-02 |
| Stage1-vs-Stage4 |
1.535610E-01 |
| Stage2-vs-Stage3 |
7.644200E-01 |
| Stage2-vs-Stage4 |
8.968800E-01 |
| Stage3-vs-Stage4 |
8.807200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.638000E-04 |
| Normal-vs-AfricanAmerican |
1.576460E-02 |
| Normal-vs-Asian |
4.181500E-02 |
| Caucasian-vs-AfricanAmerican |
3.105600E-01 |
| Caucasian-vs-Asian |
8.214800E-01 |
| AfricanAmerican-vs-Asian |
5.074200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.187810E-01 |
| Normal-vs-Female |
8.46890000000267E-05 |
| Male-vs-Female |
2.946100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.30329999999501E-05 |
| Normal-vs-Age(41-60Yrs) |
2.075500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.546150E-01 |
| Normal-vs-Age(81-100Yrs) |
7.242400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.161790E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.244800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.273960E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.814000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.103000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.924000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.525000E-01 |
| Classical-VS-Follicular |
5.449200E-04 |
| Classical-VS-Other |
1.431980E-01 |
| Classical-VS-Normal |
1.66293999999123E-05 |
| Tall-VS-Follicular |
1.628380E-01 |
| Tall-VS-Other |
9.583700E-02 |
| Tall-VS-Normal |
2.848100E-02 |
| Follicular-VS-Other |
5.127400E-01 |
| Follicular-VS-Normal |
5.827200E-01 |
| Other-VS-Normal |
5.244400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.914410E-02 |
| Normal-vs-N1 |
4.420200E-02 |
| N0-vs-N1 |
4.490200E-01 |
|
|
